European Commercial Potential for Inhalation Drug Delivery in Diabetes

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

European Commercial Potential for Inhalation Drug Delivery in Diabetes, Executive SummaryExecutive Summary of European Commercial Potential for Inhalation Drug Delivery in DiabetesIntroductionThe Commercial Potential For Inhalation InsulinFuture Competitive StructureCompeting Non-invasive Insulin Delivery TechnologiesStructure of the ReportEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, IntroductionIntroduction to European Commercial Potential for Inhalation Drug Delivery in DiabetesIntroductionEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, Current Diabetes TreatmentOverview of DiabetesDiabetes PrevalenceType 1 DiabetesType 2 DiabetesInsulinsInsulin ClassesInsulin Treatment RegimensOral AgentsOral MedicationsEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, Inhalation TechnologyPulmonary Delivery of InsulinDefinition of Inhalation Drug DeliveryConcept of Pulmonary DeliveryInhalation Device TechnologyOverview of Inhalation DevicesAerodoseAERx - iDMSAIR - Advance Inhalation ResearchInhanceTechnospheresEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, Strategic Factors for Inhalation InsulinStrategic Factors: European LevelRelative CompetitivenessData from ExuberaHealth EconomicsStructure of Drug-Device RelationshipPositioning of Inhalation DevicesOther Emerging Insulin Delivery TechnologiesEmerging Treatments for DiabetesTime to MarketParallel ImportsStrategic Factors: Country LevelPricingReimbursementEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, Forecasting Emerging Inhalation Insulin DeliveryGeneral Assumptions for Forecasting Emerging TechnologiesForecasting Emerging MarketsForecasting Revenues for Inhalation InsulinEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, Market Engineering Research for The European Diabetes Medications MarketForecast for the Total MarketMarket Overview and DefinitionsMarket Engineering Measurement SystemMarket Drivers and RestraintsMarket Engineering Revenue ForecastInsulin Market Share AnalysisMarket Engineering Research for the German Diabetes Medications MarketForecast for the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Drivers and Restraints for Inhalation InsulinMarket Engineering Revenue Forecast 2002-2009Insulin Market Share AnalysisMarket Engineering Research for the French Diabetes Medications MarketForecast for the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Drivers and Restraints for Inhalation InsulinMarket Engineering Revenue Forecast 2002-2009Insulin Market Share AnalysisMarket Engineering Research for the Italian Diabetes Medications MarketForecasts of the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Drivers and Restraints for Inhalation InsulinMarket Engineering Revenue Forecast 2002-2009Insulin Market Share AnalysisMarket Engineering Research for the United Kingdom Diabetes Medications MarketForecast for the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Drivers and Restraints for Inhalation InsulinMarket Engineering Revenue Forecast 2002-2009Insulin Market Share AnalysisMarket Engineering Research for the Spanish Diabetes Medications MarketForecast for the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Drivers and Restraints for Inhalation InsulinMarket Engineering Revenue Forecast 2002-2009Insulin Market Share AnalysisMarket Engineering Research for the Benelux Diabetes Medications MarketForecast for the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Drivers and Restraints for Inhalation InsulinMarket Engineering Revenue Forecast 2002-2009Insulin Market Share AnalysisMarket Engineering Research for the Scandinavian Diabetes Medications MarketForecast for the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Drivers and Restraints for Inhalation InsulinMarket Engineering Revenue Forecast 2002-2009Insulin Market Share AnalysisEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, Market Engineering StrategyMarket Engineering Strategic RecommendationsStrategies Based on Identifying a Medical NeedStrategies Based on ConvenienceStrategies Based on Promoting Earlier Use of Insulin in Type 2 DiabeticsStrategies Based on Health EconomicsStrategies Based on Device SubsidiesStrategies Based on Key MarketsStrategies Based on Expanding Insulin Delivery PortfolioEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, Market Engineering Awards for Inhalation Drug Delivery in DiabetesMarket Engineering AwardsMarket Engineering AwardsAward Category: Product Differentiation and InnovationEuropean Commercial Potential for Inhalation Drug Delivery in Diabetes, Database of Key Industry ParticipantsDatabase of Key Industry ParticipantsDatabase of Key Industry Participants




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.